Literature DB >> 10738935

Characterizing and reporting pelvic floor defects: the revised New York classification system.

R J Scotti1, R Flora, W M Greston, L Budnick, J Hutchinson-Colas.   

Abstract

The authors have devised a conceptual model and reporting system for characterizing, grading and staging pelvic floor defects. The system is user friendly and simple to learn and apply. It is based on commonly known anatomic landmarks and can be performed without memorizing or referring to a separate characterization and reporting plan. Completing the accompanying forms is self-explanatory and provides the information needed for proper comprehension and recording of anatomic defects. The model and reporting format have been used at our institutions for 5 years by medical students, residents, fellows and attendings. It has several advantages over the Pelvic Organ Prolapse Quantitation (POPQ) system: (1) it uses known anatomic landmarks rather than alphabetic labels; (2) it grades lateral wall defects which the POPQ system omits; (3) it recognizes and reports isolated defects or tears which present as bulges in the vaginal walls without downward linear descent (prolapse); (4) it uses a one-page reporting form and a one-page checklist and vaginal profile; (5) it can be done easily in both the supine and the standing positions; (6) it requires simple instruments and a disposable measuring tape available in most office settings; (7) it includes urethral hypermobility in its reporting scheme; (8) it includes cervical length, perineal descent and other measurements in its reporting scheme; and (9) it is similar enough to the POPQ system that easy conversion to, and integration with, the POPQ reporting form and vaginal profile is possible. Prospective trials testing the validity of this system and comparing it with the POPQ system for validity, reliability, reproducibility, test-retest analysis, and interobserver and intraobserver variance are warranted.

Entities:  

Mesh:

Year:  2000        PMID: 10738935     DOI: 10.1007/s001920050010

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  8 in total

Review 1.  A review of the pelvic organ prolapse quantification system in China.

Authors:  Yi-ting Wang; Jun-ying Jiang; Jin-song Han
Journal:  Int Urogynecol J       Date:  2015-09-09       Impact factor: 2.894

2.  Is the pelvic organ prolapse quantification system (POPQ) being used? A survey of members of the International Continence Society (ICS) and the American Urogynecologic Society (AUGS).

Authors:  W Auwad; R M Freeman; S Swift
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-05-18

Review 3.  Use of pelvic organ prolapse staging systems in published articles of selected specialized journals.

Authors:  Alejandro Daniel Treszezamsky; Lauren Rascoff; Azin Shahryarinejad; Michael D Vardy
Journal:  Int Urogynecol J       Date:  2010-01-06       Impact factor: 2.894

4.  POP-Q 2.0: its time has come!

Authors:  Oz Harmanli
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

5.  The POP-Q system: two decades of progress and debate.

Authors:  Richard C Bump
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

6.  Pessary use in advanced pelvic organ prolapse.

Authors:  Kenneth Powers; George Lazarou; Andrea Wang; Julie LaCombe; Giti Bensinger; Wilma M Greston; Magdy S Mikhail
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-05-10

7.  Magnetic resonance imaging of abdominal versus vaginal prolapse surgery with mesh.

Authors:  Shimon Ginath; Alan D Garely; Jonathan S Luchs; Azin Shahryarinejad; Cedric K Olivera; Sue Zhou; Charles J Ascher-Walsh; Alexander Condrea; Michael L Brodman; Michael D Vardy
Journal:  Int Urogynecol J       Date:  2012-04-28       Impact factor: 2.894

8.  Pessary reduction and postoperative cure of retention in women with anterior vaginal wall prolapse.

Authors:  George Lazarou; Richard J Scotti; Magdy S Mikhail; Huang Sue Zhou; Kenneth Powers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.